PREVALENCE OF CHRONIC GLOMERULONEPHRITIS AND ITS CLINICAL TYPES IN THE REPUBLIC OF UZBEKISTAN
Abstract
Chronic glomerulonephritis (CGN) is a chronic immune-inflammatory disease of the renal glomerular apparatus and is one of the leading causes of chronic kidney disease progression, often resulting in chronic renal failure. The disease is characterized by proteinuria, hematuria, arterial hypertension, and a gradual decline in renal function. CGN remains an important epidemiological and clinical problem for the healthcare system of the Republic of Uzbekistan.Although large-scale national epidemiological studies on CGN in Uzbekistan are limited, available clinical observations indicate a relatively high prevalence of the disease.
References
1. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. (2021). KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney International, 100(4 Suppl), S1–S276
2. Glassock, R. J., & Fervenza, F. C. (2020). Glomerular diseases: New insights and future therapies. The Lancet, 395(10225), 234–246.
3. Levey, A. S., Eckardt, K. U., Dorman, N. M., et al. (2020). Nomenclature for kidney function and disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Kidney International, 97(6), 1117–1129.
4. Ismailov, S. I., Karimov, A. A., & Abdullaeva, N. M. (2022). Clinical features of chronic glomerulonephritis in children in Uzbekistan. Medical Journal of Uzbekistan, 3, 45–49.
5. Saidova, M. A., & Rakhimov, B. R. (2023). Immunogenetic aspects of chronic glomerulonephritis in the Uzbek population. Central Asian Journal of Medical Sciences, 4(2), 78–84.
6. Lv, J., Zhang, H., Wong, M. G., et al. (2021). Effect of intensive blood pressure lowering on the progression of chronic kidney disease. BMJ, 372, n123.
